Search

Mark Allen Pershouse

from Missoula, MT
Age ~67
Get Report
Also known as:
Mark A Pershouse, Mark Perhouse
Phone and address:
117 Addie Ct, Missoula, MT 59803
(406) 251-4408
Related to:
Helen A PershouseJohn Stanley PershouseElizabeth A Putnam, 67Harry A PutnamRebecca E Pershouse, 34Anna Pershouse, 31
Connected to:
Edward C Pershouse, 62Mark M Pershyn, 54Ernest R Persi, 64Shawn C Persi, 47Estefany E Persia, 35Susan M Persia, 77Carmine Persiani, 93Donnalisa Persiani, 59Marlynn A Persiani, 55Christopher J Persic, 60

Mark Pershouse Phones & Addresses

  • 117 Addie Ct, Missoula, MT 59803 (406) 251-4408
  • 4065 Mcdermed Dr, Houston, TX 77025 (713) 667-7414

Work

Position: Sales Occupations

Education

Degree: Graduate or professional degree

Resumes

Resumes

Mark Pershouse Photo 1

Associate Professor

View page
Location:
Missoula, MT
Industry:
Higher Education
Work:
University of Montana May 2018 - May 2019
Faculty Senate Chair-Elect
University of Montana May 2018 - May 2019
Faculty Senate Chair at University of Montana
U of M May 2018 - May 2019
Associate Professor
Baylor College of Medicine Aug 1998 - Aug 2000
Postdoctoral Fellow
Education:
The University of Texas Health Science Center at Houston (Uthealth) 1984 - 1993
Doctorates, Doctor of Philosophy, Philosophy Texas Tech University 1976 - 1980
Bachelors, Bachelor of Science, Biology
Skills:
Genetics
Cancer
Genomics
Molecular Biology
Research
Microarray
Higher Education
Cell Biology
Scientific Writing
Biochemistry
Cell Culture
Healthcare
Molecular Genetics
Fluorescence Microscopy
Pcr
Western Blotting
Toxicology
Hardware Diagnostics
Medicine
Hospitals
Elisa
Immunology
Lifesciences
Flow Cytometry
Life Sciences
Pharmacy
Teaching
Science
Public Speaking
Grant Writing
Data Analysis
Program Development
Community Outreach
Healrth Professions Advising
Health Professions Advising
Interests:
Children
Civil Rights and Social Action
Education
Arts and Culture
Health
Languages:
Spanish
Mark Pershouse Photo 2

Associate Professor

View page
Location:
Missoula, MT
Industry:
Higher Education
Work:
University of Montana
Associate Professor

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mark Pershouse
Associate Professor
Montana Cancer Institute Fdn
Membership Organizations, Nec, Nsk
500 W Broadway St, Missoula, MT 59802
900 N Orange St, Missoula, MT 59802

Publications

Us Patents

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
6482795, Nov 19, 2002
Filed:
Aug 26, 1998
Appl. No.:
09/140749
Inventors:
Peter Steck - Bellaire TX
Mark A. Pershouse - Houston TX
Samar A. Jasser - Houston TX
Alfred W. K. Yung - Houston TX
Sean V. Tavtigian - Salt Lake City UT
Assignee:
Myriad Genetics, Inc. - Salt Lake City UT
Board of Regents, University of Texas System - Austin TX
International Classification:
A61K 3800
US Classification:
514 2, 514 12, 514 21, 530350
Abstract:
A specific region of chromosome 10 (10q23. 3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23. 3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23. 3, also are disclosed.

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
7129040, Oct 31, 2006
Filed:
Nov 1, 2004
Appl. No.:
10/979642
Inventors:
Peter Steck - Bellaire TX, US
Mark A. Pershouse - Houston TX, US
Samar A. Jasser - Houston TX, US
Alfred W. K. Yung - Houston TX, US
Sean V. Tavtigian - Salt Lake City UT, US
International Classification:
C12Q 1/68
G01N 33/53
G01N 33/48
G01N 33/566
US Classification:
435 4, 435 6, 435 71, 436 64, 436501
Abstract:
A specific region of chromosome 10 (10q23. 3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23. 3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23. 3, also are disclosed.

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
7217795, May 15, 2007
Filed:
Nov 19, 2002
Appl. No.:
10/299003
Inventors:
Peter Steck - Bellaire TX, US
Mark A. Pershouse - Houston TX, US
Samar A. Jasser - Houston TX, US
Alfred W. K. Yung - Houston TX, US
Sean V. Tavtigian - Salt Lake City UT, US
Assignee:
Myriad Genetics, Inc. - Salt Lake City UT
Board of Regents, The University of Texas Systems - Austin TX
International Classification:
C07K 16/00
US Classification:
5303873, 530350, 530380, 530385, 5303871, 5303881, 5303882, 5303884, 4241341, 4241411, 4241351, 424 91, 435188, 435 91
Abstract:
A specific region of chromosome 10 (10q23. 3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23. 3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23. 3, also are disclosed.

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
7732576, Jun 8, 2010
Filed:
Oct 30, 2006
Appl. No.:
11/590556
Inventors:
Peter Steck - Bellaire TX, US
Mark A. Pershouse - Houston TX, US
Samar A. Jasser - Houston TX, US
Alfred W. K. Yung - Houston TX, US
Sean V. Tavtigian - Lyons, FR
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C07K 16/00
US Classification:
5303871, 530350, 5303873, 5303879, 5303881
Abstract:
A specific region of chromosome 10 (10q23. 3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23. 3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23. 3, also are disclosed.

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
20070048811, Mar 1, 2007
Filed:
Oct 30, 2006
Appl. No.:
11/590578
Inventors:
Peter Steck - Bellaire TX, US
Mark Pershouse - Houston TX, US
Samar Jasser - Houston TX, US
Alfred Yung - Houston TX, US
Sean Tavtigian - Lyon, FR
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
G01N 33/574
C07K 16/30
US Classification:
435007230, 530388800
Abstract:
A specific region of chromosome 10 (10q23.3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23.3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23.3, also are disclosed.

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
20100190176, Jul 29, 2010
Filed:
Apr 1, 2010
Appl. No.:
12/752827
Inventors:
Peter Steck - Bellaire TX, US
Mark A. Pershouse - Houston TX, US
Samar A. Jasser - Houston TX, US
Alfred W.K. Yung - Houston TX, US
Sean V. Tavtigian - Salt Lake City UT, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
C12Q 1/68
C07H 21/04
C12P 19/34
US Classification:
435 6, 536 231, 435 915
Abstract:
A specific region of chromosome 10 (10q23.3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23.3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23.3, also are disclosed.

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
20120315631, Dec 13, 2012
Filed:
Apr 23, 2012
Appl. No.:
13/453324
Inventors:
Peter Steck - Bellaire TX, US
Mark A. Pershouse - Houston TX, US
Samar A. Jasser - Houston TX, US
Alfred W.K. Yung - Houston TX, US
Sean V. Tavtigian - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
Board of Regents, The University of Texas System - Austin TX
International Classification:
C12Q 1/68
G01N 21/64
US Classification:
435 611
Abstract:
A specific region of chromosome 10 (10q23.3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23.3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23.3, also are disclosed.

Tumor Suppressor Designated Ts10Q23.3

View page
US Patent:
62622420, Jul 17, 2001
Filed:
Jan 30, 1997
Appl. No.:
8/791115
Inventors:
Peter Steck - Bellaire TX
Mark A. Pershouse - Houston TX
Samar A. Jasser - Houston TX
W. K. Alfred Yung - Houston TX
Sean V. Tavtigian - Salt Lake City UT
Assignee:
Board of Regents, The University of Texas System - Austin TX
Myriad Genetics, Inc. - Salt Lake City UT
International Classification:
C07H 204
C07K 14475
C07K 1447
C12Q 168
US Classification:
536 231
Abstract:
A specific region of chromosome 10 (10q23. 3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23. 3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23. 3, also are disclosed.
Control profile
Mark Allen Pershouse from Missoula, MT, age ~67 Get Report